| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
AmyloidosisCRPGenome wide association study| 1 | 2006 | C-reactive protein (CRP)-lowering agents. | 
| + | - | nl | Cardiovasc Drug Rev 24(1):33-50 (2006) Prasad K |
| 2 | 2000 | Regulation of phagocytic leukocyte activities by C-reactive protein. |
| + | - | nl | J Leukoc Biol 67(4):495-500 (2000) |
| 3 | 2009 | Regulation of cell function by isoforms of C-reactive protein: a comparative analysis. |
| + | - | nl | Acta Biochim Pol 56(1):17-31 (2009) |
| 4 | 2004 | C-reactive Protein. |
| + | - | nl | J Biol Chem 279(47):48487-90 (2004) |
| 5 | 2005 | Single-dose therapy for lupus nephritis: C-reactive protein, nature's own dual scavenger and immunosuppressant. |
| + | - | nl | Arthritis Rheum 52(2):378-81 (2005) Ogden CA |
| 6 | 2005 | A new perspective on the biology of C-reactive protein. |
| + | - | nl | Circ Res 97(7):609-11 (2005) Yeh ET |
| 7 | 2003 | C-reactive protein as a regulator of autoimmunity and inflammation. |
| + | - | nl | Arthritis Rheum 48(6):1475-7 (2003) |
| 8 | 2009 | C-reactive protein: how conformational changes influence inflammatory properties. |
| + | - | nl | Cell Cycle 8(23):3885-92 (2009) |
| 9 | 2011 | Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. |
| + | - | nl | Circulation 123(7):731-8 (2011) |
| 10 | 2011 | C-reactive protein (CRP) is not a mere marker, but an active pathogenic substance. |
| + | - | nl | Circ J 75(7):1579-80 (2011) Miura T |
| 11 | 2009 | Platelets affect the structure and function of C-reactive protein. |
| + | - | nl | Circ Res 105(2):109-11 (2009) Filep JG |
| 12 | 2003 | C-reactive protein: a critical update. |
| + | - | nl | J Clin Invest 111(12):1805-12 (2003) |
| 13 | 2009 | C-reactive protein and malignancy: clinico-pathological association and therapeutic implication. |
| + | - | nl | Chang Gung Med J 32(5):471-82 (2009) |
| 14 | 2008 | High-sensitivity C-reactive protein as a predictor of all-cause mortality: implications for research and patient care. |
| + | - | nl | Clin Chem 54(2):234-7 (2008) Ridker PM |
